This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

USMD Expands To Support The Growing Healthcare Needs Of Patients In The Dallas-Fort Worth Metroplex

USMD Holdings, Inc. ( NASDAQ: USMD), a physician-led integrated health system, announced today that three new physicians—Tamika Perry, D.O.; Ranjitha Rishikesh, M.D.; and Charlie Ruby, D.O.—have joined USMD Affiliated Services. These physicians have been added to support the expanding healthcare needs of the communities USMD serves.

Drs. Perry, Rishikesh and Ruby increase the number of USMD primary care physicians serving seniors and accepting Medicare patients to 95, and further confirm USMD’s commitment to caring for and providing quality healthcare to seniors in the Dallas-Fort Worth metropolitan area.

“I’m pleased to welcome Dr. Perry, Dr. Rishikesh and Dr. Ruby to USMD,” said John House, M.D., chairman and chief executive officer of USMD Holdings. “The addition of these physicians allows USMD to continue providing the high-quality, comprehensive and personalized care that each of our patients deserve.”

Dr. Perry joins USMD at its new Cedar Hill Clinic. Dr. Perry completed her medical training at Philadelphia College of Osteopathic Medicine and her residency in family medicine at Methodist Charlton Medical Center in Dallas. Dr. Perry also has a Master’s in Public Health from University of North Texas Health Science Center.

Dr. Rishikesh joins USMD at its Denton North Clinic. She completed her medical degree and her residency in internal medicine at The Wright Center for Medical Education in Scranton, Pa.

Dr. Ruby joins USMD at its new Midlothian Clinic. Dr. Ruby completed medical training at University of North Texas Health Science Center and his residency in Family Medicine at The University of Texas Southwestern Medical Center.

About USMD Holdings, Inc.

USMD is a publicly held (NASDAQ: USMD), physician-led, integrated health system committed to exemplary patient care. Headquartered in Irving, Texas, USMD serves the Dallas-Fort Worth metropolitan area with more than 250 physicians and associate practitioners, and provides healthcare services to patients in just under 20 different specialties at its two hospitals, nine cancer treatment centers and nearly 70 physician clinics, many of which are multi-specialty. All 26 of USMD’s primary care clinics have been accredited by the Patient-Centered Medical Home Program, a recognition program that is part of the National Committee for Quality Assurance. This recognition means that USMD’s primary care clinics successfully display and utilize evidence-based, patient-centered processes that focus on highly coordinated patient care and long-term patient relationships. For more information about USMD, visit

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs